|
Potent Activity of Bictegravir (BIC; GS-9883), a Novel Unboosted HIV-1 Integrase Strand Transfer Inhibitor (INSTI), Against Patient Isolates with INSTI-Resistance [2]
|
|
|
Reported by Jules Levin
14th European Workshop on HIV & Hepatitis
May 25-27, 2016
Rome, Italy
Kirsten White, Tomas Cihlar and Michael D. Miller
Gilead Sciences, Foster City, CA
![HIV1](../images/062316/062316-1/HIV1.gif)
![HIV2](../images/062316/062316-1/HIV2.gif)
![HIV3](../images/062316/062316-1/HIV3.gif)
![HIV4](../images/062316/062316-1/HIV4.gif)
![HIV5](../images/062316/062316-1/HIV5.gif)
![HIV6](../images/062316/062316-1/HIV6.gif)
|
|
|
|
|
|
|